Identification Generic Name (2S,2'S)-2,2'-(1,2-Hydrazinediylbis{methylene[(2S)-1-oxo-2,1-hexanediyl]imino})bis(6-amino-N-phenylhexanamide) DrugBank Accession Number DB03648 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 Download  MOL SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (2S,2'S)-2,2'-(1,2-Hydrazinediylbis{methylene[(2S)-1-oxo-2,1-hexanediyl]imino})bis(6-amino-N-phenylhexanamide) (DB03648) ×  Close Weight Average: 694.966  Monoisotopic: 694.489402508  Chemical Formula C 38 H 62 N 8 O 4 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Formylmethionine deformylase, putative Not Available Plasmodium falciparum (isolate 3D7) Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Classification Not classified Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key YFMXWONORHSZEM-DDOVKQMLSA-N InChI InChI=1S/C38H62N8O4/c1-3-5-17-29(35(47)45-33(23-13-15-25-39)37(49)43-31-19-9-7-10-20-31)27-41-42-28-30(18-6-4-2)36(48)46-34(24-14-16-26-40)38(50)44-32-21-11-8-12-22-32/h7-12,19-22,29-30,33-34,41-42H,3-6,13-18,23-28,39-40H2,1-2H3,(H,43,49)(H,44,50)(H,45,47)(H,46,48)/t29-,30+,33-,34-/m0/s1 IUPAC Name (2S)-6-amino-2-[(2R)-2-({2-[(2S)-2-{[(1S)-5-amino-1-(phenylcarbamoyl)pentyl]carbamoyl}-2-butylethyl]hydrazin-1-yl}methyl)hexanamido]-N-phenylhexanamide SMILES [H]N([H])CCCC[C@H](N([H])C(=O)[C@@H](CCCC)CN([H])N([H])C[C@@H](CCCC)C(=O)N([H])[C@@H](CCCCN([H])[H])C(=O)N([H])C1=CC=CC=C1)C(=O)N([H])C1=CC=CC=C1 References General References Not Available External Links PubChem Compound 5496887 PubChem Substance 46507126 PDBe Ligand BL5 PDB Entries 1rl4 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.00414 mg/mL ALOGPS logP 2.29 ALOGPS logP 4.13 Chemaxon logS -5.2 ALOGPS pKa (Strongest Acidic) 12.44 Chemaxon pKa (Strongest Basic) 10.5 Chemaxon Physiological Charge 2 Chemaxon Hydrogen Acceptor Count 8 Chemaxon Hydrogen Donor Count 8 Chemaxon Polar Surface Area 192.5 Å 2 Chemaxon Rotatable Bond Count 27 Chemaxon Refractivity 223.32 m 3 ·mol -1 Chemaxon Polarizability 80.3 Å 3 Chemaxon Number of Rings 2 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9565 Blood Brain Barrier + 0.6538 Caco-2 permeable - 0.6123 P-glycoprotein substrate Substrate 0.7541 P-glycoprotein inhibitor I Non-inhibitor 0.5586 P-glycoprotein inhibitor II Non-inhibitor 0.9411 Renal organic cation transporter Non-inhibitor 0.903 CYP450 2C9 substrate Non-substrate 0.8592 CYP450 2D6 substrate Non-substrate 0.7791 CYP450 3A4 substrate Non-substrate 0.6173 CYP450 1A2 substrate Non-inhibitor 0.8866 CYP450 2C9 inhibitor Non-inhibitor 0.7979 CYP450 2D6 inhibitor Non-inhibitor 0.8745 CYP450 2C19 inhibitor Non-inhibitor 0.687 CYP450 3A4 inhibitor Non-inhibitor 0.7845 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9301 Ames test Non AMES toxic 0.5412 Carcinogenicity Carcinogens  0.524 Biodegradation Not ready biodegradable 0.9891 Rat acute toxicity 2.3957 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.939 hERG inhibition (predictor II) Non-inhibitor 0.6369    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Formylmethionine deformylase, putative Kind Protein Organism Plasmodium falciparum (isolate 3D7) Pharmacological action Unknown General Function Peptide deformylase activity Specific Function Removes the formyl group from the N-terminal Met of newly synthesized proteins. Gene Name Not Available Uniprot ID Q8I372 Uniprot Name Peptide deformylase Molecular Weight 28393.87 Da × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52 